Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints

Rikard Landberg*, Claudine Manach, Frederiek-Maarten Kerckhof, Anne-Marie Minihane, Rasha Noureldin M Saleh, Baukje De Roos, Francisco Tomas-Barberan, Christine Morand, Tom Van de Wiele

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

PURPOSE: The health-promoting potential of food-derived plant bioactive compounds is evident but not always consistent across studies. Large inter-individual variability may originate from differences in digestion, absorption, distribution, metabolism and excretion (ADME). ADME can be modulated by age, sex, dietary habits, microbiome composition, genetic variation, drug exposure and many other factors. Within the recent COST Action POSITIVe, large-scale literature surveys were undertaken to identify the reasons and extent of inter-individual variability in ADME of selected plant bioactive compounds of importance to cardiometabolic health. The aim of the present review is to summarize the findings and suggest a framework for future studies designed to investigate the etiology of inter-individual variability in plant bioactive ADME and bioefficacy.

RESULTS: Few studies have reported individual data on the ADME of bioactive compounds and on determinants such as age, diet, lifestyle, health status and medication, thereby limiting a mechanistic understanding of the main drivers of variation in ADME processes observed across individuals. Metabolomics represent crucial techniques to decipher inter-individual variability and to stratify individuals according to metabotypes reflecting the intrinsic capacity to absorb and metabolize bioactive compounds.

CONCLUSION: A methodological framework was developed to decipher how the contribution from genetic variants or microbiome variants to ADME of bioactive compounds can be predicted. Future study design should include (1) a larger number of study participants, (2) individual and full profiling of all possible determinants of internal exposure, (3) the presentation of individual ADME data and (4) incorporation of omics platforms, such as genomics, microbiomics and metabolomics in ADME and efficacy studies.

Original languageEnglish
Pages (from-to)21-36
Number of pages16
JournalEuropean Journal of Nutrition
Volume58
Issue numberSuppl 2
Early online date23 Oct 2019
DOIs
Publication statusPublished - Nov 2019

Fingerprint

Plant Dispersal
Metabolomics
Microbiota
Edible Plants
Health
Feeding Behavior
Genomics
Health Status
Life Style
Digestion
Diet

Keywords

  • Plant bioactive compounds
  • Cardiometabolic
  • Inter-individual variation
  • personalized nutrition
  • Personalized nutrition
  • RISK
  • BIOAVAILABILITY
  • COMT GENOTYPE
  • DEMETHYLASE
  • FLAVANONES
  • O-METHYLTRANSFERASE GENOTYPE
  • VASCULAR FUNCTION
  • ASSOCIATION
  • CONSUMPTION
  • CYP1A2 GENOTYPE

Cite this

Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints. / Landberg, Rikard; Manach, Claudine; Kerckhof, Frederiek-Maarten; Minihane, Anne-Marie; Saleh, Rasha Noureldin M; De Roos, Baukje; Tomas-Barberan, Francisco; Morand, Christine; Van de Wiele, Tom.

In: European Journal of Nutrition, Vol. 58, No. Suppl 2, 11.2019, p. 21-36.

Research output: Contribution to journalReview article

Landberg, Rikard ; Manach, Claudine ; Kerckhof, Frederiek-Maarten ; Minihane, Anne-Marie ; Saleh, Rasha Noureldin M ; De Roos, Baukje ; Tomas-Barberan, Francisco ; Morand, Christine ; Van de Wiele, Tom. / Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints. In: European Journal of Nutrition. 2019 ; Vol. 58, No. Suppl 2. pp. 21-36.
@article{f009d21a9876439ea78d851a61b5a59c,
title = "Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints",
abstract = "PURPOSE: The health-promoting potential of food-derived plant bioactive compounds is evident but not always consistent across studies. Large inter-individual variability may originate from differences in digestion, absorption, distribution, metabolism and excretion (ADME). ADME can be modulated by age, sex, dietary habits, microbiome composition, genetic variation, drug exposure and many other factors. Within the recent COST Action POSITIVe, large-scale literature surveys were undertaken to identify the reasons and extent of inter-individual variability in ADME of selected plant bioactive compounds of importance to cardiometabolic health. The aim of the present review is to summarize the findings and suggest a framework for future studies designed to investigate the etiology of inter-individual variability in plant bioactive ADME and bioefficacy.RESULTS: Few studies have reported individual data on the ADME of bioactive compounds and on determinants such as age, diet, lifestyle, health status and medication, thereby limiting a mechanistic understanding of the main drivers of variation in ADME processes observed across individuals. Metabolomics represent crucial techniques to decipher inter-individual variability and to stratify individuals according to metabotypes reflecting the intrinsic capacity to absorb and metabolize bioactive compounds.CONCLUSION: A methodological framework was developed to decipher how the contribution from genetic variants or microbiome variants to ADME of bioactive compounds can be predicted. Future study design should include (1) a larger number of study participants, (2) individual and full profiling of all possible determinants of internal exposure, (3) the presentation of individual ADME data and (4) incorporation of omics platforms, such as genomics, microbiomics and metabolomics in ADME and efficacy studies.",
keywords = "Plant bioactive compounds, Cardiometabolic, Inter-individual variation, personalized nutrition, Personalized nutrition, RISK, BIOAVAILABILITY, COMT GENOTYPE, DEMETHYLASE, FLAVANONES, O-METHYLTRANSFERASE GENOTYPE, VASCULAR FUNCTION, ASSOCIATION, CONSUMPTION, CYP1A2 GENOTYPE",
author = "Rikard Landberg and Claudine Manach and Frederiek-Maarten Kerckhof and Anne-Marie Minihane and Saleh, {Rasha Noureldin M} and {De Roos}, Baukje and Francisco Tomas-Barberan and Christine Morand and {Van de Wiele}, Tom",
note = "Acknowledgements This article is based upon work from COST Action FA1403 POSITIVe (Interindividual variation in response to consumption of plant food bioactives and determinants involved) supported by COST (European Cooperation in Science and Technology; www.cost.eu). The authors also acknowledge all the partners involved in working group 1 of the COST Action POSITIVe. Author contributions RL, CM and TVdW conceived and drafted the manuscript. FMK, A-MM, RNMS and FT-B added specific sections and all the authors contributed with critical intellectual input, read and revised the final draft. Funding COST (European Cooperation in Science and Technology) Action FA1403 (2014–2018).",
year = "2019",
month = "11",
doi = "10.1007/s00394-019-02095-1",
language = "English",
volume = "58",
pages = "21--36",
journal = "European Journal of Nutrition",
issn = "1436-6207",
publisher = "D. Steinkopff-Verlag",
number = "Suppl 2",

}

TY - JOUR

T1 - Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints

AU - Landberg, Rikard

AU - Manach, Claudine

AU - Kerckhof, Frederiek-Maarten

AU - Minihane, Anne-Marie

AU - Saleh, Rasha Noureldin M

AU - De Roos, Baukje

AU - Tomas-Barberan, Francisco

AU - Morand, Christine

AU - Van de Wiele, Tom

N1 - Acknowledgements This article is based upon work from COST Action FA1403 POSITIVe (Interindividual variation in response to consumption of plant food bioactives and determinants involved) supported by COST (European Cooperation in Science and Technology; www.cost.eu). The authors also acknowledge all the partners involved in working group 1 of the COST Action POSITIVe. Author contributions RL, CM and TVdW conceived and drafted the manuscript. FMK, A-MM, RNMS and FT-B added specific sections and all the authors contributed with critical intellectual input, read and revised the final draft. Funding COST (European Cooperation in Science and Technology) Action FA1403 (2014–2018).

PY - 2019/11

Y1 - 2019/11

N2 - PURPOSE: The health-promoting potential of food-derived plant bioactive compounds is evident but not always consistent across studies. Large inter-individual variability may originate from differences in digestion, absorption, distribution, metabolism and excretion (ADME). ADME can be modulated by age, sex, dietary habits, microbiome composition, genetic variation, drug exposure and many other factors. Within the recent COST Action POSITIVe, large-scale literature surveys were undertaken to identify the reasons and extent of inter-individual variability in ADME of selected plant bioactive compounds of importance to cardiometabolic health. The aim of the present review is to summarize the findings and suggest a framework for future studies designed to investigate the etiology of inter-individual variability in plant bioactive ADME and bioefficacy.RESULTS: Few studies have reported individual data on the ADME of bioactive compounds and on determinants such as age, diet, lifestyle, health status and medication, thereby limiting a mechanistic understanding of the main drivers of variation in ADME processes observed across individuals. Metabolomics represent crucial techniques to decipher inter-individual variability and to stratify individuals according to metabotypes reflecting the intrinsic capacity to absorb and metabolize bioactive compounds.CONCLUSION: A methodological framework was developed to decipher how the contribution from genetic variants or microbiome variants to ADME of bioactive compounds can be predicted. Future study design should include (1) a larger number of study participants, (2) individual and full profiling of all possible determinants of internal exposure, (3) the presentation of individual ADME data and (4) incorporation of omics platforms, such as genomics, microbiomics and metabolomics in ADME and efficacy studies.

AB - PURPOSE: The health-promoting potential of food-derived plant bioactive compounds is evident but not always consistent across studies. Large inter-individual variability may originate from differences in digestion, absorption, distribution, metabolism and excretion (ADME). ADME can be modulated by age, sex, dietary habits, microbiome composition, genetic variation, drug exposure and many other factors. Within the recent COST Action POSITIVe, large-scale literature surveys were undertaken to identify the reasons and extent of inter-individual variability in ADME of selected plant bioactive compounds of importance to cardiometabolic health. The aim of the present review is to summarize the findings and suggest a framework for future studies designed to investigate the etiology of inter-individual variability in plant bioactive ADME and bioefficacy.RESULTS: Few studies have reported individual data on the ADME of bioactive compounds and on determinants such as age, diet, lifestyle, health status and medication, thereby limiting a mechanistic understanding of the main drivers of variation in ADME processes observed across individuals. Metabolomics represent crucial techniques to decipher inter-individual variability and to stratify individuals according to metabotypes reflecting the intrinsic capacity to absorb and metabolize bioactive compounds.CONCLUSION: A methodological framework was developed to decipher how the contribution from genetic variants or microbiome variants to ADME of bioactive compounds can be predicted. Future study design should include (1) a larger number of study participants, (2) individual and full profiling of all possible determinants of internal exposure, (3) the presentation of individual ADME data and (4) incorporation of omics platforms, such as genomics, microbiomics and metabolomics in ADME and efficacy studies.

KW - Plant bioactive compounds

KW - Cardiometabolic

KW - Inter-individual variation

KW - personalized nutrition

KW - Personalized nutrition

KW - RISK

KW - BIOAVAILABILITY

KW - COMT GENOTYPE

KW - DEMETHYLASE

KW - FLAVANONES

KW - O-METHYLTRANSFERASE GENOTYPE

KW - VASCULAR FUNCTION

KW - ASSOCIATION

KW - CONSUMPTION

KW - CYP1A2 GENOTYPE

U2 - 10.1007/s00394-019-02095-1

DO - 10.1007/s00394-019-02095-1

M3 - Review article

VL - 58

SP - 21

EP - 36

JO - European Journal of Nutrition

JF - European Journal of Nutrition

SN - 1436-6207

IS - Suppl 2

ER -